Definitive Contract HHSN268201400016C
Award Date 10/11/13
Potential Completion Date 10/10/14
Potential Value $75K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $672,660 firm fixed-price contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of an Illumina HiSeq DNA sequencer. The contract does not have a set-aside designation. Illumina, a for-profit manufacturer of genetic and genomic analysis instruments and reagents, has provided sequencing systems and related goods and services to support research and diagnostic applications across...
- This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of sequencing services. The contract has a ceiling value of $95,569.54 and does not include any set-aside provisions. Illumina, a manufacturer of genetic analysis instruments and reagents, has previously received prime federal contracts and grants from agencies including the NIH, Centers...
- This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $646,396.36 and no set-aside designation. Illumina, a manufacturer of sequencing and array-based genomic analysis solutions, will provide a range of sequencing systems, reagents, and services to support NHLBI's research and diagnostics needs. Illumina has a history of...
- This is a firm fixed price federal contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. to provide the HiSeq 2500 sequencing system to the NHLBI Division of Intramural Research (DIR). The contract has a ceiling value of $647,403.80 and a period of performance ending on March 24, 2015. There is no set-aside designation associated with this award. Illumina, Inc. is a manufacturer and provider of...
- This is a firm fixed-price delivery order awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The $48,994.05 contract is for the procurement of an Illumina MiSeq I100 sequencing system and associated reagents and services, to support high-quality DNA sequencing and genomic research at NHLBI. The contract has an ultimate...
- This is a firm fixed-price delivery order awarded by the National Heart, Lung, and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian federal agency. The $42,511.56 contract is for Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, to provide Illumina sequencing kits and reagents to support next-generation DNA sequencing activities at the NHLBI Sequencing Core Facility. The contract has a performance period ending on...
- This is a delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for the procurement of Illumina kits and reagents to support next-generation sequencing activities at the NHLBI Sequencing Core Facility. The contract has a ceiling value of $25,696.80 and a period of performance...
- This $28,709.96 firm fixed price delivery order was awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for the maintenance and support of a NextSeq sequencing instrument to enable DNA sequencing and genomics research for NHLBI principal investigators, fellows, and staff. The award has no set-aside designation. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has...
- This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $81,254.25 and a period of performance ending on August 18, 2017. It does not have a set-aside designation. The contract provides for Illumina to deliver a range of genomic sequencing systems, reagents, consumables, and support services to the NHLBI. This includes Illumina's...
- This firm fixed-price delivery order was awarded by the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $110,254.47, is with Illumina, Inc., a manufacturer of genomic sequencing systems and consumables. Illumina has provided these products and associated services to support genomic research and analysis across various federal agencies in the past. This order does not include any set-aside...